Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the Liver
Open Access
- 19 October 2021
- journal article
- review article
- Published by Xia & He Publishing in Journal of Clinical and Translational Hepatology
- Vol. 10 (2), 329-338
- https://doi.org/10.14218/jcth.2021.00178
Abstract
Nonalcoholic fatty liver disease (NAFLD) is a multisystemic clinical condition that presents with a wide spectrum of extrahepatic manifestations, such as obesity, type 2 diabetes mellitus, metabolic syndrome, cardiovascular diseases, chronic kidney disease, extrahepatic malignancies, cognitive disorders, and polycystic ovarian syndrome. Among NAFLD patients, the most common mortality etiology is cardiovascular disorders, followed by extrahepatic malignancies, diabetes mellitus, and liver-related complications. Furthermore, the severity of extrahepatic diseases is parallel to the severity of NAFLD. In clinical practice, awareness of the associations of concomitant diseases is of major importance for initiating prompt and timely screening and multidisciplinary management of the disease spectrum. In 2020, a consensus from 22 countries redefined the disease as metabolic (dysfunction)-associated fatty liver disease (MAFLD), which resulted in the redefinition of the corresponding population. Although the patients diagnosed with MAFLD and NAFLD mostly overlap, the MAFLD and NAFLD populations are not identical. In this review, we compared the associations of key extrahepatic diseases between NAFLD and MAFLD.Keywords
This publication has 148 references indexed in Scilit:
- Low Bone Mineral Density in Chinese Adults with Nonalcoholic Fatty Liver DiseaseInternational Journal of Endocrinology, 2013
- Clinicopathological characteristics and metabolic profiles of non-alcoholic fatty liver disease in Indian patients with normal body mass index: Do they differ from obese or overweight non-alcoholic fatty liver disease?Indian Journal of Endocrinology and Metabolism, 2013
- Patients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular eventsJournal of Hepatology, 2012
- Non-alcoholic fatty liver disease across the spectrum of hypothyroidismJournal of Hepatology, 2012
- National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participantsThe Lancet, 2011
- Relationship between Kidney Function and Liver Histology in Subjects with Nonalcoholic SteatohepatitisClinical Journal of the American Society of Nephrology, 2010
- Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severityAnnals of Medicine, 2010
- Microalbuminuria in nondiabetic patients with nonalcoholic fatty liver disease: association with liver fibrosisMetabolism, 2010
- Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasisJournal of Hepatology, 2009
- Steatohepatitis: A tale of two “hits”?Gastroenterology, 1998